Sleep apnea is a disorder that causes people to ... suggested a different way to treat her apnea. He recommended the Inspire device, which is implanted near a person's collarbone and keeps their ...

Inspire Medical Systems released preliminary results indicated second-quarter and full-year revenue above analysts' estimates. The sleep apnea device maker expects second quarter sales to be 30% ...

The company develops minimally invasive solutions for patients with obstructive sleep apnea (OSA ... wouldn’t be good candidates for Inspire’s device, which is designed to prevent airway ...

Eli Lilly stock rose Monday after Zepbound received Food and Drug Administration (FDA) approval as a treatment for obstructive sleep apnea among adults with obesity.

Obstructive Sleep Apnea affects 1 in 15 Americans, likely more, and treatment has often involved inconvenient treatments like CPAP machines. A new device called Inspire offers new alternatives for ...